Masoud H. Manjili
Affiliations: | Virginia Commonwealth University, Richmond, VA, United States |
Area:
Cell BiologyGoogle:
"Masoud Manjili"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Koelsch N, Manjili MH. (2023) From Reductionistic Approach to Systems Immunology Approach for the Understanding of Tumor Microenvironment. International Journal of Molecular Sciences. 24 |
| Qian J, Yu X, Liu Z, et al. (2023) SRA inhibition improves antitumor potency of antigen-targeted chaperone vaccine. Frontiers in Immunology. 14: 1118781 |
| Manjili MH, Khazaie K. (2022) Pattern recognition of tumor dormancy and relapse beyond cell-intrinsic and cell-extrinsic pathways. Seminars in Cancer Biology. 78: 1-4 |
| Manjili SH, Isbell M, Ghochaghi N, et al. (2021) Multifaceted functions of chronic inflammation in regulating tumor dormancy and relapse. Seminars in Cancer Biology |
| Liu Z, Guo C, Das SK, et al. (2021) Engineering T cells to express tumoricidal MDA-7/IL-24 enhances cancer immunotherapy. Cancer Research |
| Aqbi HF, Coleman C, Zarei M, et al. (2020) Local and distant tumor dormancy during early stage breast cancer are associated with the predominance of infiltrating T effector subsets. Breast Cancer Research : Bcr. 22: 116 |
| Patel NH, Sohal SS, Manjili MH, et al. (2020) The Roles of Autophagy and Senescence in the Tumor Cell Response to Radiation. Radiation Research. 194: 103-115 |
| Manjili RH, Zarei M, Habibi M, et al. (2020) COVID-19 as an Acute Inflammatory Disease. Journal of Immunology (Baltimore, Md. : 1950) |
| Manjili MH. (2020) The premise of personalized immunotherapy for cancer dormancy. Oncogene |
| Jahanban-Esfahlan R, Seidi K, Manjili MH, et al. (2019) Tumor Cell Dormancy: Threat or Opportunity in the Fight against Cancer. Cancers. 11 |